The Progress and Evolving Trends in Nucleic-Acid-Based Therapies
Biomolecules · 05.03.2025 · 15 (3) · 376
DOI: 10.3390/biom15030376 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 05.03.2025. Verfasst von Yunlong Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and School of Life Sciences, Tiangong University, Tianjin 300387, China. Hauptthemen laut MEDLINE: Genetic Therapy, Oligonucleotides, Antisense, Nucleic Acids. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 230 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Nucleic-acid-based therapies have emerged as a pivotal domain within contemporary biomedical science, marked by significant advancements in recent years. These innovative treatments primarily operate through the precise binding of DNA or RNA molecules to discrete target genes, subsequently suppressing the expression of the target proteins. The spectrum of nucleic-acid-based therapies encompasses antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), microRNAs (miRNAs), and messenger RNAs (mRNAs), etc. Compared to more traditional medicinal approaches, nucleic-acid-based therapies stand out for their highly targeted action on specific genes, as well as their potential for chemical modification to improve resistance to nucleases, ensuring sustained therapeutic activity and mitigating immunogenicity concerns. Nevertheless, these molecules’ limited cellular permeability necessitates the deployment of delivery vectors to enhance their intracellular uptake and stability. As nucleic-acid-based therapies progressively display promising pharmacodynamic profiles, there has been a burgeoning interest in these treatments for applications in clinical research. This review aims to summarize the variety of nucleic acid drugs and their mechanisms, evaluate the present status in research and application, discourse on prospective trends, and potential challenges ahead. These innovative therapeutics are anticipated to assume a pivotal role in the management of a wide array of diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and School of Life Sciences, Tiangong University, Tianjin 300387, China.
ORCID-Profile: Yunlong Liu, Xiuping Fu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, Y., Wang, C., Fu, X., & Ren, M. (2025). The Progress and Evolving Trends in Nucleic-Acid-Based Therapies. Biomolecules, 15(3), 376. https://doi.org/10.3390/biom15030376
Vancouver
Liu Y, Wang C, Fu X, Ren M. The Progress and Evolving Trends in Nucleic-Acid-Based Therapies. Biomolecules. 2025;15(3):376. doi:10.3390/biom15030376
BibTeX
@article{Liu2025,
author = {Liu, Yunlong and Wang, Chunmiao and Fu, Xiuping and Ren, Mengtian},
title = {The Progress and Evolving Trends in Nucleic-Acid-Based Therapies},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {3},
pages = {376},
doi = {10.3390/biom15030376}
}
EUVIMED